4-[(7S,10S,13R,14R,17R)-7-Hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pent-4-enoic acid(CAS: 852936-69-7)

The compound is a crystalline solid with a molecular weight of approximately 533.5 g/mol. It has a high melting point and low solubility in water but is soluble in organic solvents. It is less reactive than other fatty acids but shows potential reactivity in hydrogenation and esterification reactions. It is used in pharmaceutical and cosmetic industries due to its unique chemical structure.

The compound is synthesized through a multistep process involving hydroxylation, methylation, and esterification reactions. Commonly, it is synthesized using metal-catalyzed hydrogenation processes followed by selective esterification. The synthesis yields a product with high purity and good selectivity, making it suitable for pharmaceutical applications.

This compound is primarily used in the pharmaceutical industry for drug development, particularly in anticancer and anti-inflammatory medications. It is also utilized in the cosmetic industry for its potential skin care benefits. Its unique structure makes it valuable in research and development for new therapeutic agents.

Proper personal protective equipment (PPE) should be worn, including gloves, goggles, and a lab coat. This compound should be handled in a fume hood to minimize inhalation risk. Spills should be cleaned up with appropriate absorbents and disposed of according to local regulations. Always consult the safety data sheet (SDS) for detailed handling instructions and emergency procedures.